









Markets
/
Stocks
/
nasdaq-cnc
/

Centene Corp

CNC

32.650USD

-0.610-1.83%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

16.04BMarket Cap

7.81P/E TTM



Centene Corp

32.650

-0.610-1.83%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-12

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

20 / 72

Overall Ranking

143 / 4724

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 21 analysts

Hold

Current Rating

35.656

Target Price

+7.20%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 174.96.

Fairly Valued

The company’s latest PE is 8.04, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 499.70M shares, decreasing 2.86% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 58.15M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 1.34.

Financial Health

Currency: USD Updated：2025-09-12

The company's current financial score is 7.95, which is higher than the Healthcare Providers & Services industry's average of 7.15. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 46.62B, representing a year-over-year increase of 15.38%, while its net profit experienced a year-over-year increase of 12.73%.

Score

Industry at a Glance

Previous score

7.95

Change



Financials

9.46

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.44

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.61

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.04

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.21

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-12

The company’s current valuation score is 1.80, which is lower than the Healthcare Providers & Services industry's average of 2.15. Its current P/E ratio is 6.98, which is 25.88% below the recent high of 8.78 and -4.73% above the recent low of 7.31.

Score

Industry at a Glance

Previous score

1.80

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 20/72

No Data

Earnings Forecast

Currency: USD Updated：2025-09-12

The company’s current earnings forecast score is 6.48, which is lower than the Healthcare Providers & Services industry's average of 7.66. The average price target for Centene Corp is 30.50, with a high of 91.50 and a low of 24.00.

Score

Industry at a Glance

Previous score

6.48

Change

Support & Resistance

No Data

Analyst Rating

Based on 21 analysts

Hold

Current Rating

35.656

Target Price

+7.20%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Centene Corp

CNC

UnitedHealth Group Inc

UNH

Humana Inc

HUM

Cigna Group

Elevance Health Inc

ELV

Molina Healthcare Inc

MOH

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-12

The company’s current price momentum score is 8.49, which is higher than the Healthcare Providers & Services industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 30.98 and the support level at 25.89, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.09

Change

-0.29

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

1.450

Neutral

RSI(14)

64.211

Neutral

STOCH(KDJ)(9,3,3)

71.037

Neutral

ATR(14)

1.351

High Vlolatility

CCI(14)

177.182

Buy

Williams %R

36.415

Buy

TRIX(12,20)

0.387

Sell

StochRSI(14)

78.247

Sell

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

31.702

Buy

MA10

30.486

Buy

MA20

29.712

Buy

MA50

28.841

Buy

MA100

43.025

Sell

MA200

51.694

Sell

Institutional Confidence

Currency: USD Updated：2025-09-12

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 7.19. The latest institutional shareholding proportion is 101.74%, representing a quarter-over-quarter increase of 1.06%. The largest institutional shareholder is The Vanguard, holding a total of 58.15M shares, representing 11.84% of shares outstanding, with 1.47% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

57.29M

-1.00%

BlackRock Institutional Trust Company, N.A.

27.42M

+1.51%

Norges Bank Investment Management (NBIM)

25.36M

+19.54%

State Street Global Advisors (US)

22.67M

-0.41%

Fidelity Management & Research Company LLC

20.20M

+26.24%

Harris Associates L.P.

Star Investors

21.14M

-16.79%

Capital World Investors

14.91M

-14.82%

Geode Capital Management, L.L.C.

12.93M

+3.67%

AQR Capital Management, LLC

11.05M

+42.71%

Politan Capital Management, L.P.

8.53M

-2.74%

Risk Assessment

Currency: USD Updated：2025-09-12

The company's beta value is 0.44. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.